{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:05:55Z","timestamp":1783544755599,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jocn.2021.03.019","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T04:52:26Z","timestamp":1618462346000},"page":"185-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Facilitators and barriers to medication adherence among stroke survivors in India"],"prefix":"10.1016","volume":"88","author":[{"given":"S.D.","family":"Shani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.N.","family":"Sylaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sankara Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Raman Kutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jocn.2021.03.019_b0005","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1161\/STROKEAHA.110.602615","article-title":"Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis","volume":"42","author":"Mohan","year":"2011","journal-title":"Stroke"},{"issue":"9596","key":"10.1016\/j.jocn.2021.03.019_b0010","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(07)61448-2","article-title":"Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison","volume":"370","author":"Rothwell","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jocn.2021.03.019_b0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ageing\/afn282","article-title":"Human and Economic Burden of Stroke","volume":"38","author":"Di Carlo","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.jocn.2021.03.019_b0020","doi-asserted-by":"crossref","unstructured":"Burkhart PV, Sabat\u00e9 E (2003) Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 35(3):207.","DOI":"10.1111\/j.1547-5069.2003.tb00001.x"},{"issue":"7","key":"10.1016\/j.jocn.2021.03.019_b0025","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/STROKEAHA.110.579375","article-title":"Antihypertensive drug use and adherence after stroke: are there sex differences?","volume":"41","author":"Khan","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2021.03.019_b0030","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1212\/WNL.0000000000003910","article-title":"Racial differences in statin adherence following hospital discharge for ischemic stroke","volume":"88","author":"Albright","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jocn.2021.03.019_b0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11606-012-2308-x","article-title":"Key barriers to medication adherence in survivors of strokes and transient ischemic attacks","volume":"28","author":"Kronish","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"8","key":"10.1016\/j.jocn.2021.03.019_b0040","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1161\/01.STR.32.8.1884","article-title":"Compliance with secondary prevention of ischemic stroke: a prospective evaluation","volume":"32","author":"Sappok","year":"2001","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jocn.2021.03.019_b0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/2396987316647187","article-title":"Redictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: A systematic review and meta-analyses","volume":"1","author":"Al Shaikh","year":"2016","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.jocn.2021.03.019_b0050","doi-asserted-by":"crossref","unstructured":"Chen MJ, Wu CC, Wan L, PhD, Zou G, PhD; Neidlinger SH (2018) Association between medication adherence and admission blood pressure among patients with ischemic stroke. J Cardiovasc Nurs 34(2): E1\u2013E8.","DOI":"10.1097\/JCN.0000000000000541"},{"key":"10.1016\/j.jocn.2021.03.019_b0055","first-page":"503","article-title":"Southern Africa Stroke Prevention Initiative (SASPI) study","volume":"82","author":"Thorogood","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jocn.2021.03.019_b0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f4586","article-title":"Non-adherence to medication increases stroke risk in patients with high blood pressure","volume":"347","author":"Mayor","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2021.03.019_b0065","doi-asserted-by":"crossref","unstructured":"Perreault S, Yu A, Cote A, Dragomir A,White-Guay B, Dumas S. Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes. Neurology 2012;79:2037\u201343.","DOI":"10.1212\/WNL.0b013e3182749e56"},{"key":"10.1016\/j.jocn.2021.03.019_b0070","doi-asserted-by":"crossref","unstructured":"Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521\u201330.","DOI":"10.1097\/01.mlr.0000163641.86870.af"},{"issue":"5-6","key":"10.1016\/j.jocn.2021.03.019_b0075","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000362718","article-title":"Barriers and facilitators for medication adherence in stroke patients: a qualitative study conducted in French neurological rehabilitation units","volume":"72","author":"Bauler","year":"2014","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2021.03.019_b0080","doi-asserted-by":"crossref","unstructured":"Souter C, Kinnear A, Kinnear M, Mead G. Optimisation of secondary prevention of stroke: a qualitative study of stroke patients' beliefs, concerns and difficulties with their medicines. Int J Pharm Pract 2014;22:424\u201332.","DOI":"10.1111\/ijpp.12104"},{"key":"10.1016\/j.jocn.2021.03.019_b0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/STROKEAHA.109.566950","article-title":"Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke","volume":"41","author":"Glader","year":"2010","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.jocn.2021.03.019_b0090","doi-asserted-by":"crossref","first-page":"e016814","DOI":"10.1136\/bmjopen-2017-016814","article-title":"Barriers and facilitators to adherence to secondary stroke prevention medications after stroke: analysis of survivors and caregivers views from an online stroke forum","volume":"7","author":"Jamison","year":"2017","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.jocn.2021.03.019_b0095","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000438","article-title":"Health system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic review","volume":"3","author":"Banerjee","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.jocn.2021.03.019_b0100","doi-asserted-by":"crossref","unstructured":"Durai Pandian J, Toor G, Arora R, Kaur P, Dheeraj KV, Bhullar RS, Sylaja PN. Complementary and alternative medicine treatments among stroke patients in India.Top Stroke Rehabil 2013;19(5):384\u201394.","DOI":"10.1310\/tsr1905-384"},{"key":"10.1016\/j.jocn.2021.03.019_b0105","doi-asserted-by":"crossref","unstructured":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) JAMA. 16;285(19):2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.jocn.2021.03.019_b0110","doi-asserted-by":"crossref","unstructured":"Glycemic targets:Standards of Medical Care in Diabetes\u20142019. Diabetes Care 42(Suppl. 1):S61\u2013S70.","DOI":"10.2337\/dc19-S006"},{"issue":"7","key":"10.1016\/j.jocn.2021.03.019_b0115","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2021.03.019_b0120","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12160-017-9906-0","article-title":"Psychological determinants of medication adherence in stroke survivors: a systematic review of observational studies","volume":"51","author":"Crayton","year":"2017","journal-title":"Ann BehavMed"},{"issue":"2","key":"10.1016\/j.jocn.2021.03.019_b0125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/ijerph16020196","article-title":"Adherence to treatment in stroke patients","volume":"16","author":"Cheiloudaki","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.jocn.2021.03.019_b0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/2396987316646026","article-title":"Inequalities in medication adherence to statin treatment after stroke: A nationwide observational study","volume":"1","author":"Sj\u00f6lander","year":"2016","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.jocn.2021.03.019_b0135","first-page":"837","article-title":"How payment scheme affects patients' adherence to medications? A systematic review","volume":"10","author":"Aziz","year":"2016","journal-title":"Dove Med Press"},{"issue":"4","key":"10.1016\/j.jocn.2021.03.019_b0140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.07.001","article-title":"Awareness, treatment, and control of vascular risk factors among stroke survivors","volume":"19","author":"Brenner","year":"2010","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821001296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821001296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:26:38Z","timestamp":1760822798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586821001296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":28,"alternative-id":["S0967586821001296"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2021.03.019","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Facilitators and barriers to medication adherence among stroke survivors in India","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2021.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}